No credit card. No commitment.
5000+ G2 reviews
Cor Clinical Research
Medical practice
Oklahoma City, Oklahoma
corclinicalresearch.comCor Clinical Research
Medical practiceOklahoma City, Oklahoma
EmployeesCor Clinical Research's financial review
Cor Clinical Research's Revenue (Yearly)
7M
Employees
2
Cor Clinical Research information
COR Clinical Research is a medical research facility in Oklahoma City that is dedicated to finding new medical treatments, medications and other options for treating diseases and disorders. Principal Investigator Dr. Clinton N. Corder has more than 40 years' experience in medical research with hundreds of clinical trials to his credit. Each of COR's Phase 1 through Phase 4 clinical trials is regul...
COR Clinical Research is a medical research facility in Oklahoma City that is dedicated to finding new medical treatments, medications and other options for treating diseases and disorders. Principal Investigator Dr. Clinton N. Corder has more than 40 years' experience in medical research with hundreds of clinical trials to his credit. Each of COR's Phase 1 through Phase 4 clinical trials is regulated by the U.S. Food and Drug Administration (FDA) and a study-specific Investigational Review Board (IRB).
Cor Clinical Research industries
Medical practice
Medical practices
Hospital & health care
Cor Clinical Research's financial review
Cor Clinical Research's Revenue (Yearly)
7M
Employees
2
Employee Metrics
Technologies
Notable Alumni
Employees
Lead Patient Recuruitment Specialist
Physician
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
